184 related articles for article (PubMed ID: 38660475)
1.
Chellen T; Bausart M; Maus P; Vanvarenberg K; Limaye N; Préat V; Malfanti A
Mater Today Bio; 2024 Jun; 26():101057. PubMed ID: 38660475
[TBL] [Abstract][Full Text] [Related]
2. Combination of hyaluronic acid conjugates with immunogenic cell death inducer and CpG for glioblastoma local chemo-immunotherapy elicits an immune response and induces long-term survival.
Catania G; Rodella G; Vanvarenberg K; Préat V; Malfanti A
Biomaterials; 2023 Mar; 294():122006. PubMed ID: 36701998
[TBL] [Abstract][Full Text] [Related]
3. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
Berger G; Knelson EH; Jimenez-Macias JL; Nowicki MO; Han S; Panagioti E; Lizotte PH; Adu-Berchie K; Stafford A; Dimitrakakis N; Zhou L; Chiocca EA; Mooney DJ; Barbie DA; Lawler SE
Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2111003119. PubMed ID: 35787058
[TBL] [Abstract][Full Text] [Related]
4. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
Bielecki PA; Lorkowski ME; Becicka WM; Atukorale PU; Moon TJ; Zhang Y; Wiese M; Covarrubias G; Ravichandran S; Karathanasis E
Nanoscale Horiz; 2021 Feb; 6(2):156-167. PubMed ID: 33400743
[TBL] [Abstract][Full Text] [Related]
5. STING-Activating Polymer-Drug Conjugates for Cancer Immunotherapy.
Sheehy TL; Kwiatkowski AJ; Arora K; Kimmel BR; Schulman JA; Gibson-Corley K; Wilson JT
bioRxiv; 2024 Apr; ():. PubMed ID: 38585879
[TBL] [Abstract][Full Text] [Related]
6. Combining cisplatin and a STING agonist into one molecule for metalloimmunotherapy of cancer.
Zhang S; Song D; Yu W; Li J; Wang X; Li Y; Zhao Z; Xue Q; Zhao J; Li JP; Guo Z
Natl Sci Rev; 2024 Jan; 11(1):nwae020. PubMed ID: 38332843
[TBL] [Abstract][Full Text] [Related]
7. Modification of Extracellular Matrix Enhances Oncolytic Adenovirus Immunotherapy in Glioblastoma.
Kiyokawa J; Kawamura Y; Ghouse SM; Acar S; Barçın E; Martínez-Quintanilla J; Martuza RL; Alemany R; Rabkin SD; Shah K; Wakimoto H
Clin Cancer Res; 2021 Feb; 27(3):889-902. PubMed ID: 33257429
[TBL] [Abstract][Full Text] [Related]
8. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
[TBL] [Abstract][Full Text] [Related]
9. STING activation counters glioblastoma by vascular alteration and immune surveillance.
Joseph JV; Blaavand MS; Cai H; Vernejoul F; Knopper RW; Lindhardt TB; Skipper KA; Axelgaard E; Reinert L; Mikkelsen JG; Borghammer P; Degn SE; Perouzel E; Hager H; Hansen B; Kalucka JM; Vendelbo M; Paludan SR; Thomsen MK
Cancer Lett; 2023 Nov; 579():216480. PubMed ID: 37931834
[TBL] [Abstract][Full Text] [Related]
10. Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF; Lu ED; Badillo O; Karimi S; Liu EV; Tamaki W; Rancan C; Downey KM; Stultz J; Sinha M; McHenry LK; Nasholm NM; Chuntova P; Sundström A; Genoud V; Shahani SA; Wang LD; Brown CE; Walker PR; Swartling FJ; Fong L; Okada H; Weiss WA; Hellström M
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34083417
[TBL] [Abstract][Full Text] [Related]
11. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
[TBL] [Abstract][Full Text] [Related]
12. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
[TBL] [Abstract][Full Text] [Related]
13. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract][Full Text] [Related]
14. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
[No Abstract] [Full Text] [Related]
15. Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context.
Czapla J; Drzyzga A; Matuszczak S; Cichoń T; Rusin M; Jarosz-Biej M; Pilny E; Smolarczyk R
Front Oncol; 2023; 13():1249524. PubMed ID: 37655095
[TBL] [Abstract][Full Text] [Related]
16. PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING-Type I Interferon Signaling in Glioblastoma.
Mondal I; Das O; Sun R; Gao J; Yu B; Diaz A; Behnan J; Dubey A; Meng Z; Eskandar E; Xu B; Lu RO; Ho WS
Cancer Res; 2023 Aug; 83(15):2527-2542. PubMed ID: 37219874
[TBL] [Abstract][Full Text] [Related]
17. STING Activated Tumor-Intrinsic Type I Interferon Signaling Promotes CXCR3 Dependent Antitumor Immunity in Pancreatic Cancer.
Vonderhaar EP; Barnekow NS; McAllister D; McOlash L; Eid MA; Riese MJ; Tarakanova VL; Johnson BD; Dwinell MB
Cell Mol Gastroenterol Hepatol; 2021; 12(1):41-58. PubMed ID: 33548597
[TBL] [Abstract][Full Text] [Related]
18. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
[TBL] [Abstract][Full Text] [Related]
19. Combining VPS34 inhibitors with STING agonists enhances type I interferon signaling and anti-tumor efficacy.
Yu Y; Bogdan M; Noman MZ; Parpal S; Bartolini E; Van Moer K; Kleinendorst SC; Bilgrav Saether K; Trésaugues L; Silvander C; Lindström J; Simeon J; Timson MJ; Al-Hashimi H; Smith BD; Flynn DL; Alexeyenko A; Viklund J; Andersson M; Martinsson J; Pokrovskaja Tamm K; De Milito A; Janji B
Mol Oncol; 2024 Mar; ():. PubMed ID: 38506049
[TBL] [Abstract][Full Text] [Related]
20. Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy.
Bao P; Gu HY; Ye JJ; He JL; Zhong Z; Yu AX; Zhang XZ
Adv Sci (Weinh); 2024 Feb; 11(6):e2306336. PubMed ID: 38072677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
